Related references
Note: Only part of the references are listed.IL-17 in Chronic Inflammation: From Discovery to Targeting
Audrey Beringer et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Bioanalytical challenges and improved detection of circulating levels of IL-13
Fang Cai et al.
BIOANALYSIS (2016)
Increased Plasma IL-17F Levels in Rheumatoid Arthritis Patients Are Responsive to Methotrexate, Anti-TNF, and T Cell Costimulatory Modulation
Manish Jain et al.
INFLAMMATION (2015)
The Selective Anti-IL17A Monoclonal Antibody Secukinumab ( AIN457) Attenuates IL17A-Induced Levels of IL6 in Human Astrocytes
Gaelle Elain et al.
GLIA (2014)
Secukinumab in Plaque Psoriasis - Results of Two Phase 3 Trials
Richard G. Langley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?
Lisa G. M. van Baarsen et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Reference range and short- and long-term biological variation of interleukin (IL)-6, IL-17A and tissue necrosis factor-alpha using high sensitivity assays
John Todd et al.
CYTOKINE (2013)
Serum levels of IL-17A in patients with relapsing-remitting multiple sclerosis treated with interferon-β
Rodica Balasa et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Interleukin 17F Level and Interferon Beta Response in Patients With Multiple Sclerosis
Hans-Peter Hartung et al.
JAMA NEUROLOGY (2013)
IL-17 cytokines in immunity and inflammation
Wei Jin et al.
EMERGING MICROBES & INFECTIONS (2013)
Targeting interleukin-17 in patients with active rheumatoid arthritis: rationale and clinical potential
Herbert Kellner
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2013)
Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal
Ph. I. Spuls et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
A Distinct Regulatory Role of Th17 Cytokines IL-17A and IL-17F in Chemokine Secretion from Lung Microvascular Endothelial Cells
Hitomi Fujie et al.
INFLAMMATION (2012)
IL-17 producing cells in host defense and atopy
Joshua D. Milner
CURRENT OPINION IN IMMUNOLOGY (2011)
The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases
Rajita Pappu et al.
IMMUNOLOGY (2011)
Treatment with Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients Induces Changes in Inflammatory Mechanism
Jaime Ramos-Cejudo et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-alpha therapy
Der-Yuan Chen et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Evaluation of heterophilic antibody blocking agents in reducing false positive interference in immunoassays for IL-17AA, IL-17FF, and IL-17AF
Laura E. DeForge et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2010)
Mechanisms of Disease: Interleukin-17 and Type 17 Helper T Cells.
Pierre Miossec et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Structure and signalling in the IL-17 receptor family
Sarah L. Gaffen
NATURE REVIEWS IMMUNOLOGY (2009)
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis
John S. Tzartos et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
SCF and IL-31 rather than IL-17 and BAFF are potential indicators in patients with allergic asthma
Z. Lei et al.
ALLERGY (2008)
Serum levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17 and IL-18 in patients with active psoriasis and correlation with disease severity
O Arican et al.
MEDIATORS OF INFLAMMATION (2005)
IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding
SG Hymowitz et al.
EMBO JOURNAL (2001)
Share Paper
